59 related articles for article (PubMed ID: 1523594)
1. Extrarenal sorbitol clearance after liver transplantation.
Paintaud G; Miguet JP; Bresson-Hadni S; Gillet M; Mantion G; Bechtel P
Therapie; 1992; 47(1):47-51. PubMed ID: 1523594
[TBL] [Abstract][Full Text] [Related]
2. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.
Zeeh J; Lange H; Bosch J; Pohl S; Loesgen H; Eggers R; Navasa M; Chesta J; Bircher J
Gastroenterology; 1988 Sep; 95(3):749-59. PubMed ID: 3396820
[TBL] [Abstract][Full Text] [Related]
3. Sorbitol as a test substance for measurement of liver plasma flow in humans.
Keiding S; Engsted E; Ott P
Hepatology; 1998 Jul; 28(1):50-6. PubMed ID: 9657096
[TBL] [Abstract][Full Text] [Related]
4. Sorbitol clearance: a parameter reflecting liver plasma flow in the rat.
Molino G; Avagnina P; Cavanna A; Ballarè M; Torchio M; Bona B; Belforte G
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):119-32. PubMed ID: 3715193
[TBL] [Abstract][Full Text] [Related]
5. [Evaluating liver functional reserve by combining D-sorbitol with indocyanine green measurement].
Gao WT; Li YM; Ji H; Yang WB
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):350-3. PubMed ID: 12837214
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive functional liver blood flow measurement: comparison between bolus dose and steady-state clearance of sorbitol in a small-rodent model.
van der Hoven B; van Pelt H; Swart EL; Bonthuis F; Tilanus HW; Bakker J; Gommers D
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G177-81. PubMed ID: 19940028
[TBL] [Abstract][Full Text] [Related]
7. Hepatic plasma flow estimated according to Fick's principle in patients with hepatic encephalopathy: evaluation of indocyanine green and D-sorbitol as test substances.
Clemmesen JO; Tygstrup N; Ott P
Hepatology; 1998 Mar; 27(3):666-73. PubMed ID: 9500692
[TBL] [Abstract][Full Text] [Related]
8. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
Jain AB; Eghtesad B; Venkataramanan R; Fontes PA; Kashyap R; Dvorchik I; Shakil AO; Kingery L; Fung JJ
Liver Transpl; 2002 Nov; 8(11):1007-13. PubMed ID: 12424713
[TBL] [Abstract][Full Text] [Related]
9. Serum and bile secretory immunoglobulins and secretory component during the early postoperative course after liver transplantation.
Bresson-Hadni S; Rossel M; Seilles E; Vuitton DA; Guennoune K; Hory B; Miguet JP; Gillet M; Vincent C; Revillard JP
Hepatology; 1991 Dec; 14(6):1046-53. PubMed ID: 1959852
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
[TBL] [Abstract][Full Text] [Related]
11. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study.
Faybik P; Krenn CG; Baker A; Lahner D; Berlakovich G; Steltzer H; Hetz H
Liver Transpl; 2004 Aug; 10(8):1060-4. PubMed ID: 15390334
[TBL] [Abstract][Full Text] [Related]
12. Intra-operative hyaluronic acid clearance predicts postoperative graft function in living related liver transplantation.
Nishizaki T; Okano S; Uchiyama H; Ikegami T; Hashimoto K; Minagawa R; Ota R; Nomoto K; Yanaga K; Sugimachi K
Int Surg; 1999; 84(3):262-5. PubMed ID: 10533789
[TBL] [Abstract][Full Text] [Related]
13. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamics after orthotopic liver transplantation: study of associated factors and long-term effects.
Gadano A; Hadengue A; Widmann JJ; Vachiery F; Moreau R; Yang S; Soupison T; Sogni P; Degott C; Durand F
Hepatology; 1995 Aug; 22(2):458-65. PubMed ID: 7635413
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of postprandial hyperglycemia in liver transplant recipients: comparison of liver transplant patients with kidney transplant patients and healthy controls.
Schneiter P; Gillet M; Chioléro R; Jéquier E; Mosimann F; Temler E; Téta D; Matter M; Wauters JP; Tappy L
Diabetes Metab; 2000 Feb; 26(1):51-6. PubMed ID: 10705104
[TBL] [Abstract][Full Text] [Related]
16. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
[TBL] [Abstract][Full Text] [Related]
17. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
Matinlauri I; Höckerstedt K; Isoniemi H
Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of acute liver failure due to fulminating hepatitis by total or partial orthotopic liver transplantation. The clinical results].
Moreno González E; García Garciá I; Loinaz Segurola C; Gómez Sanz R; González Pinto I; Maffettone V; Jiménez Romero C; Lumbreras C; Bercedo Martínez J; Ibánez Aguirre J
Minerva Chir; 1993 Apr; 48(8):369-79. PubMed ID: 8321433
[TBL] [Abstract][Full Text] [Related]
19. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation.
Trull A; Hughes V; Cooper D; Wilkins M; Gimson A; Friend P; Johnston A; Sharples L; Park G
Liver Transpl; 2002 Mar; 8(3):224-32. PubMed ID: 11910567
[TBL] [Abstract][Full Text] [Related]
20. Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria.
Monico CG; Milliner DS
Liver Transpl; 2001 Nov; 7(11):954-63. PubMed ID: 11699031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
